IBDEI2IA ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,40015,1,3,0)
;;=3^Cirrhosis of Liver,Oth
;;^UTILITY(U,$J,358.3,40015,1,4,0)
;;=4^K74.69
;;^UTILITY(U,$J,358.3,40015,2)
;;=^5008823
;;^UTILITY(U,$J,358.3,40016,0)
;;=K74.60^^152^2003^11
;;^UTILITY(U,$J,358.3,40016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40016,1,3,0)
;;=3^Cirrhosis of Liver,Unspec
;;^UTILITY(U,$J,358.3,40016,1,4,0)
;;=4^K74.60
;;^UTILITY(U,$J,358.3,40016,2)
;;=^5008822
;;^UTILITY(U,$J,358.3,40017,0)
;;=K76.0^^152^2003^12
;;^UTILITY(U,$J,358.3,40017,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40017,1,3,0)
;;=3^Fatty Liver NEC
;;^UTILITY(U,$J,358.3,40017,1,4,0)
;;=4^K76.0
;;^UTILITY(U,$J,358.3,40017,2)
;;=^5008831
;;^UTILITY(U,$J,358.3,40018,0)
;;=K76.89^^152^2003^18
;;^UTILITY(U,$J,358.3,40018,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40018,1,3,0)
;;=3^Liver Disease NEC
;;^UTILITY(U,$J,358.3,40018,1,4,0)
;;=4^K76.89
;;^UTILITY(U,$J,358.3,40018,2)
;;=^5008835
;;^UTILITY(U,$J,358.3,40019,0)
;;=K71.6^^152^2003^32
;;^UTILITY(U,$J,358.3,40019,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40019,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatitis NEC
;;^UTILITY(U,$J,358.3,40019,1,4,0)
;;=4^K71.6
;;^UTILITY(U,$J,358.3,40019,2)
;;=^5008801
;;^UTILITY(U,$J,358.3,40020,0)
;;=K75.9^^152^2003^17
;;^UTILITY(U,$J,358.3,40020,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40020,1,3,0)
;;=3^Inflammatory Liver Disease,Unspec
;;^UTILITY(U,$J,358.3,40020,1,4,0)
;;=4^K75.9
;;^UTILITY(U,$J,358.3,40020,2)
;;=^5008830
;;^UTILITY(U,$J,358.3,40021,0)
;;=K71.0^^152^2003^24
;;^UTILITY(U,$J,358.3,40021,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40021,1,3,0)
;;=3^Toxic Liver Disease w/ Cholestasis
;;^UTILITY(U,$J,358.3,40021,1,4,0)
;;=4^K71.0
;;^UTILITY(U,$J,358.3,40021,2)
;;=^5008793
;;^UTILITY(U,$J,358.3,40022,0)
;;=K71.10^^152^2003^30
;;^UTILITY(U,$J,358.3,40022,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40022,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
;;^UTILITY(U,$J,358.3,40022,1,4,0)
;;=4^K71.10
;;^UTILITY(U,$J,358.3,40022,2)
;;=^5008794
;;^UTILITY(U,$J,358.3,40023,0)
;;=K71.11^^152^2003^31
;;^UTILITY(U,$J,358.3,40023,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40023,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
;;^UTILITY(U,$J,358.3,40023,1,4,0)
;;=4^K71.11
;;^UTILITY(U,$J,358.3,40023,2)
;;=^5008795
;;^UTILITY(U,$J,358.3,40024,0)
;;=K71.2^^152^2003^23
;;^UTILITY(U,$J,358.3,40024,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40024,1,3,0)
;;=3^Toxic Liver Disease w/ Acute Hepatitis
;;^UTILITY(U,$J,358.3,40024,1,4,0)
;;=4^K71.2
;;^UTILITY(U,$J,358.3,40024,2)
;;=^5008796
;;^UTILITY(U,$J,358.3,40025,0)
;;=K71.3^^152^2003^28
;;^UTILITY(U,$J,358.3,40025,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40025,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
;;^UTILITY(U,$J,358.3,40025,1,4,0)
;;=4^K71.3
;;^UTILITY(U,$J,358.3,40025,2)
;;=^5008797
;;^UTILITY(U,$J,358.3,40026,0)
;;=K71.4^^152^2003^27
;;^UTILITY(U,$J,358.3,40026,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40026,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
;;^UTILITY(U,$J,358.3,40026,1,4,0)
;;=4^K71.4
;;^UTILITY(U,$J,358.3,40026,2)
;;=^5008798
;;^UTILITY(U,$J,358.3,40027,0)
;;=K75.81^^152^2003^19
;;^UTILITY(U,$J,358.3,40027,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40027,1,3,0)
;;=3^Nonalcoholic Steatohepatitis (NASH)
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2IA 3796 printed Apr 09, 2024@21:23:30 Page 2
IBDEI2IA ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,40015,1,3,0)
+2 ;;=3^Cirrhosis of Liver,Oth
+3 ;;^UTILITY(U,$J,358.3,40015,1,4,0)
+4 ;;=4^K74.69
+5 ;;^UTILITY(U,$J,358.3,40015,2)
+6 ;;=^5008823
+7 ;;^UTILITY(U,$J,358.3,40016,0)
+8 ;;=K74.60^^152^2003^11
+9 ;;^UTILITY(U,$J,358.3,40016,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,40016,1,3,0)
+12 ;;=3^Cirrhosis of Liver,Unspec
+13 ;;^UTILITY(U,$J,358.3,40016,1,4,0)
+14 ;;=4^K74.60
+15 ;;^UTILITY(U,$J,358.3,40016,2)
+16 ;;=^5008822
+17 ;;^UTILITY(U,$J,358.3,40017,0)
+18 ;;=K76.0^^152^2003^12
+19 ;;^UTILITY(U,$J,358.3,40017,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,40017,1,3,0)
+22 ;;=3^Fatty Liver NEC
+23 ;;^UTILITY(U,$J,358.3,40017,1,4,0)
+24 ;;=4^K76.0
+25 ;;^UTILITY(U,$J,358.3,40017,2)
+26 ;;=^5008831
+27 ;;^UTILITY(U,$J,358.3,40018,0)
+28 ;;=K76.89^^152^2003^18
+29 ;;^UTILITY(U,$J,358.3,40018,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,40018,1,3,0)
+32 ;;=3^Liver Disease NEC
+33 ;;^UTILITY(U,$J,358.3,40018,1,4,0)
+34 ;;=4^K76.89
+35 ;;^UTILITY(U,$J,358.3,40018,2)
+36 ;;=^5008835
+37 ;;^UTILITY(U,$J,358.3,40019,0)
+38 ;;=K71.6^^152^2003^32
+39 ;;^UTILITY(U,$J,358.3,40019,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,40019,1,3,0)
+42 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
+43 ;;^UTILITY(U,$J,358.3,40019,1,4,0)
+44 ;;=4^K71.6
+45 ;;^UTILITY(U,$J,358.3,40019,2)
+46 ;;=^5008801
+47 ;;^UTILITY(U,$J,358.3,40020,0)
+48 ;;=K75.9^^152^2003^17
+49 ;;^UTILITY(U,$J,358.3,40020,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,40020,1,3,0)
+52 ;;=3^Inflammatory Liver Disease,Unspec
+53 ;;^UTILITY(U,$J,358.3,40020,1,4,0)
+54 ;;=4^K75.9
+55 ;;^UTILITY(U,$J,358.3,40020,2)
+56 ;;=^5008830
+57 ;;^UTILITY(U,$J,358.3,40021,0)
+58 ;;=K71.0^^152^2003^24
+59 ;;^UTILITY(U,$J,358.3,40021,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,40021,1,3,0)
+62 ;;=3^Toxic Liver Disease w/ Cholestasis
+63 ;;^UTILITY(U,$J,358.3,40021,1,4,0)
+64 ;;=4^K71.0
+65 ;;^UTILITY(U,$J,358.3,40021,2)
+66 ;;=^5008793
+67 ;;^UTILITY(U,$J,358.3,40022,0)
+68 ;;=K71.10^^152^2003^30
+69 ;;^UTILITY(U,$J,358.3,40022,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,40022,1,3,0)
+72 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
+73 ;;^UTILITY(U,$J,358.3,40022,1,4,0)
+74 ;;=4^K71.10
+75 ;;^UTILITY(U,$J,358.3,40022,2)
+76 ;;=^5008794
+77 ;;^UTILITY(U,$J,358.3,40023,0)
+78 ;;=K71.11^^152^2003^31
+79 ;;^UTILITY(U,$J,358.3,40023,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,40023,1,3,0)
+82 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
+83 ;;^UTILITY(U,$J,358.3,40023,1,4,0)
+84 ;;=4^K71.11
+85 ;;^UTILITY(U,$J,358.3,40023,2)
+86 ;;=^5008795
+87 ;;^UTILITY(U,$J,358.3,40024,0)
+88 ;;=K71.2^^152^2003^23
+89 ;;^UTILITY(U,$J,358.3,40024,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,40024,1,3,0)
+92 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
+93 ;;^UTILITY(U,$J,358.3,40024,1,4,0)
+94 ;;=4^K71.2
+95 ;;^UTILITY(U,$J,358.3,40024,2)
+96 ;;=^5008796
+97 ;;^UTILITY(U,$J,358.3,40025,0)
+98 ;;=K71.3^^152^2003^28
+99 ;;^UTILITY(U,$J,358.3,40025,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,40025,1,3,0)
+102 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
+103 ;;^UTILITY(U,$J,358.3,40025,1,4,0)
+104 ;;=4^K71.3
+105 ;;^UTILITY(U,$J,358.3,40025,2)
+106 ;;=^5008797
+107 ;;^UTILITY(U,$J,358.3,40026,0)
+108 ;;=K71.4^^152^2003^27
+109 ;;^UTILITY(U,$J,358.3,40026,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,40026,1,3,0)
+112 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
+113 ;;^UTILITY(U,$J,358.3,40026,1,4,0)
+114 ;;=4^K71.4
+115 ;;^UTILITY(U,$J,358.3,40026,2)
+116 ;;=^5008798
+117 ;;^UTILITY(U,$J,358.3,40027,0)
+118 ;;=K75.81^^152^2003^19
+119 ;;^UTILITY(U,$J,358.3,40027,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,40027,1,3,0)
+122 ;;=3^Nonalcoholic Steatohepatitis (NASH)
